Literature DB >> 3841305

Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.

T Kuroki, J Ruf, L Whelan, A Miller, J R Wall.   

Abstract

The possibility that Graves' ophthalmopathy and autoimmune thyroid disorders may be associated because of autoimmune reactions against antigens shared between human orbital and thyroid tissues was investigated using anti-thyroglobulin (Tg) monoclonal and autoantibodies. Eleven of 16 mouse monoclonal antibodies (MCAB) tested reacted, in an enzyme-linked immunosorbent assay (ELISA), with an antigen in human orbital connective tissue membranes (OCTmem), but not with the OCT soluble fraction, or with membrane or soluble fractions of human eye muscle, lacrimal gland or skin connective tissue. The anti-OCTmem activity was absorbed by OCTmem and Tg, but not by liver membranes or bovine serum albumin (BSA). In preliminary studies four out of 113 human MCAB against thyroid or orbital tissue antigens showed reactivity restricted to Tg and OCTmem. Sera from approximately 50% of patients with autoimmune thyroid disorders, with or without ophthalmopathy, also reacted with OCTmem. The autoantibody activity correlated closely with serum titres of antithyroglobulin but not with the presence, duration, or severity of the eye disease. The OCTmem reactivity was absorbed by Tg, thyroid membranes, and OCTmem but not liver membranes, membranes prepared from other orbital tissues, or BSA. The OCTmem-Tg shared antigen site appeared not to be native thyroglobulin since, (i) MCAB and serum autoantibodies did not react with the cytosol fraction of OCT, and (ii) because the membrane antigen was not solubilizable. Because not all patients with ophthalmopathy have detectable anti-Tg antibodies and, conversely, because not all patients with detectable anti-Tg antibodies develop ophthalmopathy it is unlikely that autoimmunity against a OCTmem-Tg shared antigen is the primary mechanism of Graves' ophthalmopathy, although this possibility has not been excluded. On the other hand the reaction of anti-Tg autoantibodies with OCT membranes may be a model for other autoimmune reactions against other thyroid-orbital tissue-shared antigens. While the pathogenesis of Graves' ophthalmopathy is likely to be multifactorial, humoral and cellular reactions against primary orbital antigens, thyroid-orbitol tissue shared antigens, or both, are likely to play important roles.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3841305      PMCID: PMC1577427     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  The role of autoimmunity in hypoendocrine and hyperendocrine function: with special emphasis on autoimmune thyroid disease.

Authors:  R Volpé
Journal:  Ann Intern Med       Date:  1977-07       Impact factor: 25.391

3.  The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts.

Authors:  J C Sisson; P Kothary; H Kirchick
Journal:  J Clin Endocrinol Metab       Date:  1973-07       Impact factor: 5.958

4.  Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association.

Authors:  S C Werner
Journal:  J Clin Endocrinol Metab       Date:  1977-01       Impact factor: 5.958

5.  Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease.

Authors:  U Bogner; H Schleusener; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

6.  Graves' disease and HLA: clinical and epidemiologic associations.

Authors:  N R Farid; E Stone; G Johnson
Journal:  Clin Endocrinol (Oxf)       Date:  1980-12       Impact factor: 3.478

7.  Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy.

Authors:  A J Kroll; T Kuwabara
Journal:  Arch Ophthalmol       Date:  1966-08

8.  Effects of experimental hyper- and hypothyroidism on numbers of blood mononuclear cells and immune function in rats and guinea-pigs.

Authors:  J R Wall; P Twohig; B Chartier
Journal:  J Endocrinol       Date:  1981-10       Impact factor: 4.286

9.  Stimulating effect of triiodothyronine on cell-mediated immunity.

Authors:  C Balázs; A Leövey; M Szabó; G Bakó
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

Review 10.  Graves' ophthalmopathy.

Authors:  J R Wall; J Henderson; C R Strakosch; D M Joyner
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262

View more
  10 in total

Review 1.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

2.  A study of human-human hybridomas from patients with autoimmune thyroid disease.

Authors:  E De Bernardo; T F Davies
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

Review 3.  Polyglandular autoimmune syndrome: current concepts.

Authors:  J Meyerson; E E Lechuga-Gomez; P E Bigazzi; P G Walfish
Journal:  CMAJ       Date:  1988-04-01       Impact factor: 8.262

4.  Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.

Authors:  W M Wiersinga; T Smit; R van der Gaag; L Koornneef
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

5.  Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.

Authors:  M Mengistu; E Laryea; A Miller; J R Wall
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

6.  Acetylcholinesterase antibodies and thyroid autoimmunity.

Authors:  A P Weetman; C K Tse; W R Randall; K W Tsim; E A Barnard
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

7.  Cross-reactive antibodies in the serum of balb/c mice immunized with thyroid or eye muscle membranes.

Authors:  J R Wall; H Triller; F Chung; M Tsao; A Boucher; P Rodien; A Liberman; N Bernard
Journal:  J Endocrinol Invest       Date:  1994-02       Impact factor: 4.256

8.  Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells.

Authors:  Y Hiromatsu; H Fukazawa; J How; J R Wall
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

Review 9.  Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited.

Authors:  M Marinò; L Chiovato; S Lisi; M A Altea; C Marcocci; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 10.  Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review.

Authors:  Thayalini Shanmuganathan; Christian Girgis; Hooshang Lahooti; Bernard Champion; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2015-12-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.